logoTry Persana

OncoLens - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about OncoLens including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

OncoLens company logo

A comprehensive oncology-focused digital health platform delivering timely, precise cancer care

OncoLens is an oncology-focused digital health platform that enhances cancer care through AI-driven analytics and multidisciplinary collaboration tools.

HeadquartersAtlanta, United States
Team size10-50
Founded2017

What is OncoLens? - Company Overview & Details

OncoLens is OncoLens is an oncology-focused digital health platform that enhances cancer care through AI-driven analytics and multidisciplinary collaboration tools. Founded in 2017, the company is headquartered in Atlanta, United States.

Who Founded OncoLens?

OncoLens was founded by Anju Mathew.

Who are the Key Executives at OncoLens? - Leadership Team

OncoLens is led by experienced executives in key positions:

Chief Executive Officer (CEO) of OncoLens

Anju MathewCEO

Chief Technology Officer (CTO) of OncoLens

CTO

About Anju Mathew - CEO of OncoLens

Anju Mathew serves as the Chief Executive Officer of OncoLens, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

OncoLens Company Details & Key Information

Where is OncoLens located?

OncoLens is headquartered in Atlanta, United States.

How many employees does OncoLens have?

OncoLens has 10-50 employees.

When was OncoLens founded?

OncoLens was founded in 2017.

OncoLens Official Website

How much funding has OncoLens raised?

OncoLens has raised $16 Million across 3 funding rounds. The most recent funding was completed on 2024-10-24.

Funding Overview

OncoLens has raised a total of $16 million in its Series B funding round to enhance its oncology analytics platform.

$16 Million
Total Funding Raised
3
Funding Rounds
2024-10-24
Latest Round

OncoLens Funding History

Series B
2024-10-24
$16 Million
Series A
2021-01-13
$7.25 Million
Pre-Series A
2020-01-07
$2.5 Million

Who are the key investors in OncoLens?

OncoLens is backed by 3 key investors including BIP Capital, Martin Ventures, SeedToB Capital. These investors focus on Healthcare IT, Digital Media, Development Tools sectors.

OncoLens Investor Overview

3
Key Investors
6
Focus Areas
3
Notable Investments

Complete List of OncoLens Investors

BIP Capital

Recognized as one of the most active venture investors in the Southeast.

Investment Focus
Healthcare IT
Digital Media
Development Tools
Marketing Technology
Notable Portfolio Companies
Various health tech startups

Martin Ventures

A healthcare-focused venture capital firm.

Investment Focus
Healthcare
Notable Portfolio Companies
OncoLens

SeedToB Capital

A healthcare AI venture fund focusing on artificial intelligence initiatives.

Investment Focus
Healthcare AI
Notable Portfolio Companies
OncoLens

What sectors do OncoLens investors focus on?

The investors backing OncoLens primarily focus on Healthcare IT, Digital Media, Development Tools, Marketing Technology, Healthcare, Healthcare AI sectors.

Healthcare IT
Digital Media
Development Tools
Marketing Technology
Healthcare
Healthcare AI

Featured Investor: BIP Capital

BIP Capital

Recognized as one of the most active venture investors in the Southeast.

Notable Investments: Various health tech startups

What are OncoLens's future plans?

OncoLens OncoLens aims to further enhance its platform and expand its partnerships with cancer centers and life sciences organizations.

OncoLens Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does OncoLens face?

OncoLens has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for OncoLens

1

Patient leakage in cancer care

2

Identifying clinically eligible patients for trials

What opportunities does OncoLens have?

OncoLens has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for OncoLens

1

Expansion into international markets

2

Innovative cancer treatment solutions

OncoLens Strategic Position Summary

Key Focus Areas

OncoLens is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about OncoLens?

OncoLens has 2 recent news updates covering key business developments and market activities.

OncoLens News Overview

2
Recent Articles
Active
Media Coverage
2025-05-19
Latest Update

What is OncoLens in the news for?

OncoLens is currently featured in news for Oncolens hires Prasanth Reddy on May 19th '25. and other significant business developments.

Recent News Articles About OncoLens

Article 1
2025-05-19

Oncolens hires Prasanth Reddy on May 19th '25.

OncoLens expands board with addition of Dr. Prasanth Reddy and welcomes Advisory members Dr. Joseph Kim and Dr. Walter Curran.

prweb.com
Read News
Article 2
2024-10-25

Oncolens recognized as one of the fastest growing company in the Inc 5000's 2024.

OncoLens has raised $16 million in a series B financing round.

backlinkmonk.com
Read News

OncoLens FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about OncoLens including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

OncoLens Questions & Answers - Company Information

Q1

What is OncoLens?

OncoLens is an oncology-focused digital health platform that enhances cancer care through AI-driven analytics and multidisciplinary collaboration tools.

Q2

Who founded OncoLens?

OncoLens was founded by Anju Mathew.

Q3

Who is the CEO of OncoLens?

The CEO of OncoLens is Anju Mathew. You can find more information about them on their LinkedIn profile.

Q4

How much funding has OncoLens raised?

OncoLens has raised a total of $$16 Million across 3 funding rounds. The most recent funding was completed on 2024-10-24.

Q5

Who are the investors in OncoLens?

OncoLens's key investors include BIP Capital, Martin Ventures, SeedToB Capital.

Q6

Where is OncoLens headquartered?

OncoLens is headquartered in Atlanta, United States.

Q7

When was OncoLens founded?

OncoLens was founded in 2017.

Q8

How many employees does OncoLens have?

OncoLens has 10-50 employees.

Q9

What is OncoLens's official website?

You can visit OncoLens's official website at https://oncolens.com.

Q10

What was OncoLens's latest funding round?

OncoLens's latest funding round was a Series B round of $$16 Million completed on 2024-10-24.

Q11

Who is founder?

Anju Mathew

Q12

What does the company do?

OncoLens is an oncology-focused digital health platform that enhances cancer care through AI-driven analytics and multidisciplinary collaboration tools.

Q13

How much funding?

$16 Million

Q14

Latest funding date?

2024-10-24

Q15

Who are the investors?

BIP Capital Martin Ventures SeedToB Capital

Q16

What are the challenges?

Patient leakage in cancer care Identifying clinically eligible patients for trials

Q17

What are the opportunities?

Expansion into international markets Innovative cancer treatment solutions

Q18

Latest news?

OncoLens expands board with addition of Dr. Prasanth Reddy and welcomes Advisory members Dr. Joseph Kim and Dr. Walter Curran. OncoLens has raised $16 million in a series B financing round.

More Information About OncoLens

For additional details about OncoLens, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.